Pine Bluff  |  Hot Springs  |  El Dorado
< All Practice Areas

Cancer Linked to Belviq

Belviq, a weight loss drug first marketed in 2012, was recalled in February 2020 by the FDA. 

The recall comes after clinical testing showed a link between BELVIQ and cancer. 

BELVIQ had a tumultuous time getting certified by the FDA back in 2010 and again in 2012 after their own internal testing didn’t pass FDA qualifications and, even after gaining certification in the United States, the European Medicines Agency refused to certify it. 

The requirement of long term studies resulted in approximately 12,000 people being evaluated.

In June of 2018 the results of those studies revealed a link between Belviq and cancer. This caused the FDA to issue a safety communication on January 14, 2020 in which it warned of the connection between the drug and cancer along with a statement that it would continue to evaluate. Less than a month later, on February 13, 2020, the FDA recalled both Belviq and its long term release version Belviq XR because of the greater exposure to cancer for its users than those in the study taking the placebo. These include links to pancreatic cancer, colorectal cancer and lung cancer.

The FDA is warning users to cease use immediately. 

Arkansas Defective Drug Attorneys

If you have used BELVIQ and have been diagnosed with cancer, we urge you to call our attorneys at the Baim Law Firm.

About Us

We have been providing expert legal advice to clients across the state and regionally for more than 80 years.

Pine Bluff

301 East Sixth Avenue
Pine Bluff AR 71601
(870) 534-2941
Toll Free: 800-848-2941

Hot Springs

307 B Carpenter Dam Road
Hot Springs AR 71901
(501) 609-9800
Toll Free: 800-848-2941

Privacy Policy & Disclaimer
© Copyright 2024 - The Baim Law Firm - All Rights Reserved
menu-circlecross-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram